(2019). Effect of linagliptin vs Placebo on major cardiovascular events in adults with type 2 Diabetes and high cardiovascular and renal risk The CARMELINA Randomized Clinical Trial.
Chicago Style (17th ed.) CitationEffect of Linagliptin Vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial. 2019.
MLA (8th ed.) CitationEffect of Linagliptin Vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk The CARMELINA Randomized Clinical Trial. 2019.
Warning: These citations may not always be 100% accurate.